Table 2 Fisher's exact test comparing the difference in proportions of patients experiencing at least one toxicity event in IGRT and non-IGRT groups
From: Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy
Toxicity | % ≥ grade 2 IGRT non-IGRT p-value | % ≥ grade 3 IGRT non-IGRT p-value | ||||
|---|---|---|---|---|---|---|
Urinary frequency | 35 | 52 | 0.1144 | 7 | 23 | 0.0188 |
Cystitis | 47 | 42 | 0.6857 | 1 | 4 | 0.3243 |
Bladder spasm | 1 | 0 | 1 | 0 | 0 | NE* |
Urinary incontinence | 3 | 0 | 1 | 0 | 0 | NE |
Urinary retention | 7 | 0 | 0.3825 | 0 | 0 | NE |
Proctitis | 6 | 15 | 0.0862 | 0 | 0 | NE |
Anal skin | 8 | 8 | 1 | 0 | 0 | NE |
Diarrhoea | 3 | 15 | 0.0174 | 0 | 0 | NE |
Haemorrhoid symptoms | 4 | 8 | 0.3097 | 0 | 0 | NE |
Fatigue | 8 | 23 | 0.0271 | 0 | 0 | NE |